Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-07-22

Clinical Trial Update: Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer

View source ↗

Summary

This clinical trial update describes a cohort study evaluating the impact of chemotherapy plus bevacizumab on health-related quality of life in patients with fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Metastatic Colorectal Cancer, Quality of Life | Status: UNKNOWN